{"patient":{"id":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","gender":"female","birthDate":"1971-03","insurance":"Barmer"},"consent":{"id":"b93e4717-7b0e-4ca5-a5d6-cf8d0f7b14cf","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","status":"active"},"episode":{"id":"8ddb893f-0d55-412f-a257-9bc8bb054549","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","period":{"start":"2021-12-29"}},"diagnoses":[{"id":"ed1f151c-0707-4bbf-bb02-9654310ac1f8","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","recordedOn":"2023-12-14","icd10":{"code":"C16.0","display":"Bösartige Neubildung: Kardia","version":"2023","system":"ICD-10-GM"},"whoGrade":{"code":"III","system":"WHO-Grading-CNS-Tumors"},"histologyResults":["385926d9-51f2-4a3a-96b6-57c5effefd84"],"statusHistory":[{"status":"local","date":"2023-12-14"},{"status":"unknown","date":"2023-12-14"}],"guidelineTreatmentStatus":"no-guidelines-available"}],"familyMemberDiagnoses":[{"id":"c434f063-76d9-4a7f-8ff2-34cd55fc56b2","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","relationship":{"code":"EXT","system":"http://terminology.hl7.org/ValueSet/v3-FamilyMember"}},{"id":"b07a73a8-70ed-48f8-a745-e82e7a5907a8","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","relationship":{"code":"EXT","system":"http://terminology.hl7.org/ValueSet/v3-FamilyMember"}}],"previousGuidelineTherapies":[{"id":"6435d684-18e3-45ad-b063-cdc303f61aa2","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","diagnosis":"ed1f151c-0707-4bbf-bb02-9654310ac1f8","therapyLine":4,"medication":[{"code":"L01XC18","system":"ATC","display":"Pembrolizumab","version":"2020"},{"code":"L01XE21","system":"ATC","display":"Regorafenib","version":"2020"},{"code":"L01XC17","system":"ATC","display":"Nivolumab","version":"2020"}]},{"id":"e35731db-7447-4c4b-896a-0e90f1e68c67","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","diagnosis":"ed1f151c-0707-4bbf-bb02-9654310ac1f8","therapyLine":4,"medication":[{"code":"L01XX46","system":"ATC","display":"Olaparib","version":"2020"},{"code":"L01XX32","system":"ATC","display":"Bortezomib","version":"2020"},{"code":"L01XE02","system":"ATC","display":"Gefitinib","version":"2020"}]},{"id":"d8a46cf9-cdc9-4f0d-b106-5aa57e08c4d0","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","diagnosis":"ed1f151c-0707-4bbf-bb02-9654310ac1f8","therapyLine":1,"medication":[{"code":"L01XC28","system":"ATC","display":"Durvalumab","version":"2020"},{"code":"L01XC06","system":"ATC","display":"Cetuximab","version":"2020"},{"code":"L01XE47","system":"ATC","display":"Dacomitinib","version":"2020"}]}],"lastGuidelineTherapies":[{"id":"9152b20d-ac04-406c-b18b-5b6f7f4d1911","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","diagnosis":"ed1f151c-0707-4bbf-bb02-9654310ac1f8","therapyLine":1,"period":{"start":"2023-12-14","end":"2024-01-04"},"medication":[{"code":"L01DB01","system":"ATC","display":"Doxorubicin","version":"2020"}],"reasonStopped":{"code":"toxicity","system":"MTB-CDS:GuidelineTherapy-StopReason"}}],"ecogStatus":[{"id":"51589dd2-f48d-4c41-8740-292b88d63b30","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","effectiveDate":"2023-12-14","value":{"code":"2","system":"ECOG-Performance-Status"}},{"id":"30caf153-a30a-4a1c-9056-fd4eae2a55da","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","effectiveDate":"2023-12-14","value":{"code":"4","system":"ECOG-Performance-Status"}}],"specimens":[{"id":"40043ae5-d4cb-48e4-85c6-b34266b7693f","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","icd10":{"code":"C16.0","display":"Bösartige Neubildung: Kardia","version":"2023","system":"ICD-10-GM"},"type":"liquid-biopsy","collection":{"date":"2023-12-14","localization":"unknown","method":"liquid-biopsy"}}],"molecularPathologyFindings":[{"id":"c7622342-3297-489e-850a-26aaf1225b36","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","specimen":"40043ae5-d4cb-48e4-85c6-b34266b7693f","performingInstitute":"12244cd7-c9dd-474e-881f-b8ab5c689b85","issuedOn":"2023-12-14","note":"MolecularPathologyFinding notes..."}],"histologyReports":[{"id":"385926d9-51f2-4a3a-96b6-57c5effefd84","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","specimen":"40043ae5-d4cb-48e4-85c6-b34266b7693f","issuedOn":"2023-12-14","tumorMorphology":{"id":"592b13c7-9507-4f31-a544-5cff90e35581","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","specimen":"40043ae5-d4cb-48e4-85c6-b34266b7693f","value":{"code":"8851/3","display":"Gut differenziertes Liposarkom","version":"Zweite Revision","system":"ICD-O-3-M"},"note":"Histology finding notes..."},"tumorCellContent":{"id":"f6af339c-415c-4682-b700-499e392b4558","specimen":"40043ae5-d4cb-48e4-85c6-b34266b7693f","method":"histologic","value":0.38164}}],"ngsReports":[{"id":"223e3e6e-d99b-415e-83c0-18bcfc5729ca","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","specimen":"40043ae5-d4cb-48e4-85c6-b34266b7693f","issueDate":"2023-12-14","sequencingType":"WGS","metadata":[{"kitType":"Agilent ExomV6","kitManufacturer":"Agilent","sequencer":"Sequencer-XYZ","referenceGenome":"HG19","pipeline":"dummy/uri/to/pipeline"}],"tumorCellContent":{"id":"e865f20a-1307-4ca3-b2ef-3a863b8afde0","specimen":"40043ae5-d4cb-48e4-85c6-b34266b7693f","method":"bioinformatic","value":0.74991},"brcaness":0.39,"msi":0.35,"tmb":594349.91,"simpleVariants":[{"id":"SNV_599c38d4-af9f-416c-ad38-eb2fee8159e1","chromosome":"chr6","gene":{"ensemblId":"ENSG00000242908","hgncId":"HGNC:50301","symbol":"AADACL2-AS1","name":"AADACL2 antisense RNA 1"},"startEnd":{"start":6736035388467870105},"refAllele":"A","altAllele":"G","dnaChange":{"code":"A>G","system":"HGVS.c"},"aminoAcidChange":{"code":"Amino acid change code...","system":"HGVS.p"},"readDepth":19,"allelicFrequency":0.75,"cosmicId":"f106c745-dbaa-453f-8dca-2f584bc1e6cb","dbSNPId":"c3f51fb2-31f3-4b27-bbcc-aac52736986f","interpretation":{"code":"Probably Inactivating","system":"ClinVAR"}},{"id":"SNV_963a3ea1-a1d5-4a52-b8d4-2e969be74b7b","chromosome":"chr2","gene":{"ensemblId":"ENSG00000141338","hgncId":"HGNC:38","symbol":"ABCA8","name":"ATP binding cassette subfamily A member 8"},"startEnd":{"start":1672464855319477743},"refAllele":"T","altAllele":"C","dnaChange":{"code":"T>C","system":"HGVS.c"},"aminoAcidChange":{"code":"Amino acid change code...","system":"HGVS.p"},"readDepth":23,"allelicFrequency":0.36,"cosmicId":"bcbc96bb-0428-48c9-8c64-7d2fd884528d","dbSNPId":"c4904618-819c-4af1-b793-ca9d820371dc","interpretation":{"code":"Ambiguous","system":"ClinVAR"}},{"id":"SNV_7f35df9d-d8b1-4421-9ec7-35cf8d3c4546","chromosome":"chr5","gene":{"ensemblId":"ENSG00000149313","hgncId":"HGNC:14235","symbol":"AASDHPPT","name":"aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase"},"startEnd":{"start":4251323878559029469},"refAllele":"A","altAllele":"C","dnaChange":{"code":"A>C","system":"HGVS.c"},"aminoAcidChange":{"code":"Amino acid change code...","system":"HGVS.p"},"readDepth":37,"allelicFrequency":0.48,"cosmicId":"c3c67469-2303-4cba-9b45-424d62a0d3db","dbSNPId":"d94cb5ce-250a-471f-a571-015fe8a711c9","interpretation":{"code":"Function Changed","system":"ClinVAR"}},{"id":"SNV_22f943fd-ad99-48af-a61e-42679e851b71","chromosome":"chr2","gene":{"ensemblId":"ENSG00000167972","hgncId":"HGNC:33","symbol":"ABCA3","name":"ATP binding cassette subfamily A member 3"},"startEnd":{"start":7454627449124699972},"refAllele":"A","altAllele":"C","dnaChange":{"code":"A>C","system":"HGVS.c"},"aminoAcidChange":{"code":"Amino acid change code...","system":"HGVS.p"},"readDepth":22,"allelicFrequency":0.37,"cosmicId":"a6074760-ce24-4075-ab11-f5ab4cd6c497","dbSNPId":"3578fa1b-eb03-423c-929d-6705cd8e805c","interpretation":{"code":"Function Changed","system":"ClinVAR"}},{"id":"SNV_fe346bed-74ac-4b84-843b-7490a5823364","chromosome":"chr14","gene":{"ensemblId":"ENSG00000125257","hgncId":"HGNC:55","symbol":"ABCC4","name":"ATP binding cassette subfamily C member 4"},"startEnd":{"start":6478613836523717707},"refAllele":"G","altAllele":"T","dnaChange":{"code":"G>T","system":"HGVS.c"},"aminoAcidChange":{"code":"Amino acid change code...","system":"HGVS.p"},"readDepth":30,"allelicFrequency":0.47,"cosmicId":"14d8842e-6af9-434f-a993-32fae87a84be","dbSNPId":"1a97211e-a6f6-44be-a909-3620f34b01e2","interpretation":{"code":"Ambiguous","system":"ClinVAR"}}],"copyNumberVariants":[{"id":"CNV_ABALON_ABCA17P_high-level-gain","chromosome":"chr8","startRange":{"start":969911792064545275,"end":969911792064546084},"endRange":{"start":4404138220928659257,"end":4404138220928659925},"totalCopyNumber":2,"relativeCopyNumber":0.18,"cnA":0.87,"cnB":0.49,"reportedAffectedGenes":[{"ensemblId":"ENSG00000281376","hgncId":"HGNC:49667","symbol":"ABALON","name":"apoptotic BCL2L1-antisense long non-coding RNA"},{"ensemblId":"ENSG00000238098","hgncId":"HGNC:32972","symbol":"ABCA17P","name":"ATP binding cassette subfamily A member 17, pseudogene"}],"reportedFocality":"reported-focality...","type":"high-level-gain","copyNumberNeutralLoH":[{"ensemblId":"ENSG00000115657","hgncId":"HGNC:47","symbol":"ABCB6","name":"ATP binding cassette subfamily B member 6 (Langereis blood group)"},{"ensemblId":"ENSG00000184389","hgncId":"HGNC:30005","symbol":"A3GALT2","name":"alpha 1,3-galactosyltransferase 2"},{"ensemblId":"ENSG00000023839","hgncId":"HGNC:53","symbol":"ABCC2","name":"ATP binding cassette subfamily C member 2"},{"ensemblId":"ENSG00000127837","hgncId":"HGNC:18","symbol":"AAMP","name":"angio associated migratory cell protein"}]},{"id":"CNV_AAGAB_ABCA6_high-level-gain","chromosome":"chr3","startRange":{"start":6843968935032545040,"end":6843968935032545924},"endRange":{"start":3583631517115538627,"end":3583631517115539281},"totalCopyNumber":4,"relativeCopyNumber":0.11,"cnA":0.15,"cnB":0.29,"reportedAffectedGenes":[{"ensemblId":"ENSG00000103591","hgncId":"HGNC:25662","symbol":"AAGAB","name":"alpha and gamma adaptin binding protein"},{"ensemblId":"ENSG00000154262","hgncId":"HGNC:36","symbol":"ABCA6","name":"ATP binding cassette subfamily A member 6"}],"reportedFocality":"reported-focality...","type":"high-level-gain","copyNumberNeutralLoH":[{"ensemblId":"ENSG00000231749","hgncId":"HGNC:39983","symbol":"ABCA9-AS1","name":"ABCA9 antisense RNA 1"},{"ensemblId":"ENSG00000154265","hgncId":"HGNC:35","symbol":"ABCA5","name":"ATP binding cassette subfamily A member 5"},{"ensemblId":"ENSG00000081760","hgncId":"HGNC:21298","symbol":"AACS","name":"acetoacetyl-CoA synthetase"}]},{"id":"CNV_ABCA12_AASDHPPT_ABCC2_AARS1P1_high-level-gain","chromosome":"chr5","startRange":{"start":8487172994898555456,"end":8487172994898556127},"endRange":{"start":2329045896118581347,"end":2329045896118581894},"totalCopyNumber":3,"relativeCopyNumber":0.67,"cnA":0.47,"cnB":0.46,"reportedAffectedGenes":[{"ensemblId":"ENSG00000144452","hgncId":"HGNC:14637","symbol":"ABCA12","name":"ATP binding cassette subfamily A member 12"},{"ensemblId":"ENSG00000149313","hgncId":"HGNC:14235","symbol":"AASDHPPT","name":"aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase"},{"ensemblId":"ENSG00000023839","hgncId":"HGNC:53","symbol":"ABCC2","name":"ATP binding cassette subfamily C member 2"},{"ensemblId":"ENSG00000249038","hgncId":"HGNC:49894","symbol":"AARS1P1","name":"alanyl-tRNA synthetase 1 pseudogene 1"}],"reportedFocality":"reported-focality...","type":"high-level-gain","copyNumberNeutralLoH":[{"ensemblId":"ENSG00000141338","hgncId":"HGNC:38","symbol":"ABCA8","name":"ATP binding cassette subfamily A member 8"},{"ensemblId":"ENSG00000129673","hgncId":"HGNC:19","symbol":"AANAT","name":"aralkylamine N-acetyltransferase"},{"ensemblId":"ENSG00000242908","hgncId":"HGNC:50301","symbol":"AADACL2-AS1","name":"AADACL2 antisense RNA 1"}]},{"id":"CNV_AAAS_AADAT_high-level-gain","chromosome":"chr10","startRange":{"start":1954565432038993495,"end":1954565432038994133},"endRange":{"start":442085989067090995,"end":442085989067091164},"totalCopyNumber":4,"relativeCopyNumber":0.37,"cnA":0.98,"cnB":0.18,"reportedAffectedGenes":[{"ensemblId":"ENSG00000094914","hgncId":"HGNC:13666","symbol":"AAAS","name":"aladin WD repeat nucleoporin"},{"ensemblId":"ENSG00000109576","hgncId":"HGNC:17929","symbol":"AADAT","name":"aminoadipate aminotransferase"}],"reportedFocality":"reported-focality...","type":"high-level-gain","copyNumberNeutralLoH":[{"ensemblId":"ENSG00000023839","hgncId":"HGNC:53","symbol":"ABCC2","name":"ATP binding cassette subfamily C member 2"},{"ensemblId":"ENSG00000150967","hgncId":"HGNC:50","symbol":"ABCB9","name":"ATP binding cassette subfamily B member 9"},{"ensemblId":"ENSG00000149313","hgncId":"HGNC:14235","symbol":"AASDHPPT","name":"aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase"}]},{"id":"CNV_A3GALT2_ABCB10P4_low-level-gain","chromosome":"chr8","startRange":{"start":1779205446909981075,"end":1779205446909981845},"endRange":{"start":3151805846500148631,"end":3151805846500149455},"totalCopyNumber":4,"relativeCopyNumber":0.94,"cnA":0.3,"cnB":0.66,"reportedAffectedGenes":[{"ensemblId":"ENSG00000184389","hgncId":"HGNC:30005","symbol":"A3GALT2","name":"alpha 1,3-galactosyltransferase 2"},{"ensemblId":"ENSG00000260053","hgncId":"HGNC:31130","symbol":"ABCB10P4","name":"ABCB10 pseudogene 4"}],"reportedFocality":"reported-focality...","type":"low-level-gain","copyNumberNeutralLoH":[{"ensemblId":"ENSG00000167972","hgncId":"HGNC:33","symbol":"ABCA3","name":"ATP binding cassette subfamily A member 3"},{"ensemblId":"ENSG00000231749","hgncId":"HGNC:39983","symbol":"ABCA9-AS1","name":"ABCA9 antisense RNA 1"},{"ensemblId":"ENSG00000108846","hgncId":"HGNC:54","symbol":"ABCC3","name":"ATP binding cassette subfamily C member 3"},{"ensemblId":"ENSG00000197953","hgncId":"HGNC:24427","symbol":"AADACL2","name":"arylacetamide deacetylase like 2"}]},{"id":"CNV_ABCA10_AADACL2_high-level-gain","chromosome":"chrX","startRange":{"start":165156786091954061,"end":165156786091954176},"endRange":{"start":5591033364020511004,"end":5591033364020511607},"totalCopyNumber":4,"relativeCopyNumber":0.69,"cnA":0.56,"cnB":0.12,"reportedAffectedGenes":[{"ensemblId":"ENSG00000154263","hgncId":"HGNC:30","symbol":"ABCA10","name":"ATP binding cassette subfamily A member 10"},{"ensemblId":"ENSG00000197953","hgncId":"HGNC:24427","symbol":"AADACL2","name":"arylacetamide deacetylase like 2"}],"reportedFocality":"reported-focality...","type":"high-level-gain","copyNumberNeutralLoH":[{"ensemblId":"ENSG00000215458","hgncId":"HGNC:51526","symbol":"AATBC","name":"apoptosis associated transcript in bladder cancer"},{"ensemblId":"ENSG00000249038","hgncId":"HGNC:49894","symbol":"AARS1P1","name":"alanyl-tRNA synthetase 1 pseudogene 1"},{"ensemblId":"ENSG00000261524","hgncId":"HGNC:31129","symbol":"ABCB10P3","name":"ABCB10 pseudogene 3"}]},{"id":"CNV_AAMP_AADACL3_low-level-gain","chromosome":"chrX","startRange":{"start":7552444878262806955,"end":7552444878262807187},"endRange":{"start":140089034030783731,"end":140089034030784407},"totalCopyNumber":2,"relativeCopyNumber":0.57,"cnA":0.26,"cnB":0.82,"reportedAffectedGenes":[{"ensemblId":"ENSG00000127837","hgncId":"HGNC:18","symbol":"AAMP","name":"angio associated migratory cell protein"},{"ensemblId":"ENSG00000188984","hgncId":"HGNC:32037","symbol":"AADACL3","name":"arylacetamide deacetylase like 3"}],"reportedFocality":"reported-focality...","type":"low-level-gain","copyNumberNeutralLoH":[{"ensemblId":"ENSG00000121410","hgncId":"HGNC:5","symbol":"A1BG","name":"alpha-1-B glycoprotein"},{"ensemblId":"ENSG00000175899","hgncId":"HGNC:7","symbol":"A2M","name":"alpha-2-macroglobulin"},{"ensemblId":"ENSG00000257408","hgncId":"HGNC:55707","symbol":"ABCA3P1","name":"ABCA3 pseudogene 1"},{"ensemblId":"ENSG00000005471","hgncId":"HGNC:45","symbol":"ABCB4","name":"ATP binding cassette subfamily B member 4"}]}],"dnaFusions":[{"id":"DNAFusion_A3GALT2_AAGAB","fusionPartner5prime":{"chromosome":"chr16","position":569568638299166051,"gene":{"ensemblId":"ENSG00000184389","hgncId":"HGNC:30005","symbol":"A3GALT2","name":"alpha 1,3-galactosyltransferase 2"}},"fusionPartner3prime":{"chromosome":"chr1","position":1728963273084125905,"gene":{"ensemblId":"ENSG00000103591","hgncId":"HGNC:25662","symbol":"AAGAB","name":"alpha and gamma adaptin binding protein"}},"reportedNumReads":25},{"id":"DNAFusion_ABCA3_AASDHPPT","fusionPartner5prime":{"chromosome":"chr12","position":4142955940382701892,"gene":{"ensemblId":"ENSG00000167972","hgncId":"HGNC:33","symbol":"ABCA3","name":"ATP binding cassette subfamily A member 3"}},"fusionPartner3prime":{"chromosome":"chr13","position":2530447494476677762,"gene":{"ensemblId":"ENSG00000149313","hgncId":"HGNC:14235","symbol":"AASDHPPT","name":"aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase"}},"reportedNumReads":29},{"id":"DNAFusion_ABCB10P3_AAAS","fusionPartner5prime":{"chromosome":"chr19","position":216619303235013143,"gene":{"ensemblId":"ENSG00000261524","hgncId":"HGNC:31129","symbol":"ABCB10P3","name":"ABCB10 pseudogene 3"}},"fusionPartner3prime":{"chromosome":"chr20","position":7983660439294503113,"gene":{"ensemblId":"ENSG00000094914","hgncId":"HGNC:13666","symbol":"AAAS","name":"aladin WD repeat nucleoporin"}},"reportedNumReads":30},{"id":"DNAFusion_A1BG_AADACL4","fusionPartner5prime":{"chromosome":"chr19","position":2761782759714541191,"gene":{"ensemblId":"ENSG00000121410","hgncId":"HGNC:5","symbol":"A1BG","name":"alpha-1-B glycoprotein"}},"fusionPartner3prime":{"chromosome":"chr15","position":2381966877469433813,"gene":{"ensemblId":"ENSG00000204518","hgncId":"HGNC:32038","symbol":"AADACL4","name":"arylacetamide deacetylase like 4"}},"reportedNumReads":22},{"id":"DNAFusion_AAMP_ABCB9","fusionPartner5prime":{"chromosome":"chr12","position":2738282492147015127,"gene":{"ensemblId":"ENSG00000127837","hgncId":"HGNC:18","symbol":"AAMP","name":"angio associated migratory cell protein"}},"fusionPartner3prime":{"chromosome":"chr18","position":4689414126579295665,"gene":{"ensemblId":"ENSG00000150967","hgncId":"HGNC:50","symbol":"ABCB9","name":"ATP binding cassette subfamily B member 9"}},"reportedNumReads":44},{"id":"DNAFusion_AACS_ABCB10","fusionPartner5prime":{"chromosome":"chr19","position":5162788528310959454,"gene":{"ensemblId":"ENSG00000081760","hgncId":"HGNC:21298","symbol":"AACS","name":"acetoacetyl-CoA synthetase"}},"fusionPartner3prime":{"chromosome":"chr2","position":281250493569316672,"gene":{"ensemblId":"ENSG00000135776","hgncId":"HGNC:41","symbol":"ABCB10","name":"ATP binding cassette subfamily B member 10"}},"reportedNumReads":28},{"id":"DNAFusion_ABCA3_ABCA8","fusionPartner5prime":{"chromosome":"chr17","position":7239027143174816791,"gene":{"ensemblId":"ENSG00000167972","hgncId":"HGNC:33","symbol":"ABCA3","name":"ATP binding cassette subfamily A member 3"}},"fusionPartner3prime":{"chromosome":"chr20","position":3415200056745807403,"gene":{"ensemblId":"ENSG00000141338","hgncId":"HGNC:38","symbol":"ABCA8","name":"ATP binding cassette subfamily A member 8"}},"reportedNumReads":47},{"id":"DNAFusion_AATF_AASS","fusionPartner5prime":{"chromosome":"chr14","position":6207520478306983467,"gene":{"ensemblId":"ENSG00000275700","hgncId":"HGNC:19235","symbol":"AATF","name":"apoptosis antagonizing transcription factor"}},"fusionPartner3prime":{"chromosome":"chr7","position":966733822586135931,"gene":{"ensemblId":"ENSG00000008311","hgncId":"HGNC:17366","symbol":"AASS","name":"aminoadipate-semialdehyde synthase"}},"reportedNumReads":32},{"id":"DNAFusion_AATBC_AARD","fusionPartner5prime":{"chromosome":"chr9","position":6948858453904558539,"gene":{"ensemblId":"ENSG00000215458","hgncId":"HGNC:51526","symbol":"AATBC","name":"apoptosis associated transcript in bladder cancer"}},"fusionPartner3prime":{"chromosome":"chr21","position":5188489683141511746,"gene":{"ensemblId":"ENSG00000205002","hgncId":"HGNC:33842","symbol":"AARD","name":"alanine and arginine rich domain containing protein"}},"reportedNumReads":21}],"rnaFusions":[{"id":"RNAFusion_A3GALT2_ABCB6","fusionPartner5prime":{"gene":{"ensemblId":"ENSG00000184389","hgncId":"HGNC:30005","symbol":"A3GALT2","name":"alpha 1,3-galactosyltransferase 2"},"transcriptId":"f283c026-41bf-41c6-afd5-1980bd408a06","exon":"c9f963b3-4e55-4f1f-9ad1-e79b86e6e751","position":1009212469473862062,"strand":"+"},"fusionPartner3prime":{"gene":{"ensemblId":"ENSG00000115657","hgncId":"HGNC:47","symbol":"ABCB6","name":"ATP binding cassette subfamily B member 6 (Langereis blood group)"},"transcriptId":"97eabd37-cf0e-44f3-a1f1-d21543eb3b5d","exon":"c9077d54-f82f-42bb-8bc8-e79e46204085","position":6271859040431005877,"strand":"-"},"effect":"RNA Fusion effect...","cosmicId":"28f0a2f7-a923-4622-a9e4-52ecd5806066","reportedNumReads":29},{"id":"RNAFusion_ABCB10P4_A2ML1-AS1","fusionPartner5prime":{"gene":{"ensemblId":"ENSG00000260053","hgncId":"HGNC:31130","symbol":"ABCB10P4","name":"ABCB10 pseudogene 4"},"transcriptId":"2cd74611-6960-455f-9946-3962aadbbd56","exon":"f7f8f171-248f-44de-9408-37a3bfa75b4f","position":9124790507143722597,"strand":"+"},"fusionPartner3prime":{"gene":{"ensemblId":"ENSG00000256661","hgncId":"HGNC:41022","symbol":"A2ML1-AS1","name":"A2ML1 antisense RNA 1"},"transcriptId":"b16fc5d0-e8ed-40e4-9798-216ad6d4aade","exon":"1bd1a002-966b-4c1d-bb0a-7f331038e5ae","position":461028552708332541,"strand":"-"},"effect":"RNA Fusion effect...","cosmicId":"89d4c113-ca01-4804-ad46-ac20a4762389","reportedNumReads":22},{"id":"RNAFusion_A2ML1-AS2_AARS1P1","fusionPartner5prime":{"gene":{"ensemblId":"ENSG00000256904","hgncId":"HGNC:41523","symbol":"A2ML1-AS2","name":"A2ML1 antisense RNA 2"},"transcriptId":"40d495d1-f498-4b7d-8e71-e3c90af68e58","exon":"23c9ccaa-ea43-444c-8340-f18365c32e4e","position":6743012027657999130,"strand":"+"},"fusionPartner3prime":{"gene":{"ensemblId":"ENSG00000249038","hgncId":"HGNC:49894","symbol":"AARS1P1","name":"alanyl-tRNA synthetase 1 pseudogene 1"},"transcriptId":"b4337aef-0a69-483c-a603-9e3d6beefff6","exon":"6980165c-6f85-4fd3-8c66-4349187f6382","position":4014336725221699201,"strand":"-"},"effect":"RNA Fusion effect...","cosmicId":"b82c4810-5629-4ea3-b569-3fd9c7167752","reportedNumReads":25},{"id":"RNAFusion_ABCA9_ABCB10P1","fusionPartner5prime":{"gene":{"ensemblId":"ENSG00000154258","hgncId":"HGNC:39","symbol":"ABCA9","name":"ATP binding cassette subfamily A member 9"},"transcriptId":"fbbc5ac0-1d3f-476a-a1ac-4ed1456528ba","exon":"f97da06b-9d7d-48c0-b202-d58a92d57e22","position":7451485235432246024,"strand":"-"},"fusionPartner3prime":{"gene":{"ensemblId":"ENSG00000274099","hgncId":"HGNC:14114","symbol":"ABCB10P1","name":"ABCB10 pseudogene 1"},"transcriptId":"3154eb7b-4364-4394-a128-75d7eb7174a0","exon":"22661f53-bfb7-4b8a-9e5f-ca0b05cda801","position":2144193097707360397,"strand":"+"},"effect":"RNA Fusion effect...","cosmicId":"42bebec2-a56e-4b55-9dc6-986d1b421404","reportedNumReads":36},{"id":"RNAFusion_A2M-AS1_AAR2","fusionPartner5prime":{"gene":{"ensemblId":"ENSG00000245105","hgncId":"HGNC:27057","symbol":"A2M-AS1","name":"A2M antisense RNA 1"},"transcriptId":"9a631927-221f-455b-b3af-b7ed8204f8ce","exon":"1ae4eead-6101-4f79-b09e-2289476ec75e","position":8438088205780109333,"strand":"-"},"fusionPartner3prime":{"gene":{"ensemblId":"ENSG00000131043","hgncId":"HGNC:15886","symbol":"AAR2","name":"AAR2 splicing factor"},"transcriptId":"e66203bb-2b54-432c-8eb9-41b81f712602","exon":"fe1ed045-ddfa-4a7d-b0c8-6f08a2bc7249","position":4758763569629035168,"strand":"+"},"effect":"RNA Fusion effect...","cosmicId":"6f5c8a08-fa74-41da-9a3e-c5965a8d6978","reportedNumReads":32},{"id":"RNAFusion_ABCB7_AADAT","fusionPartner5prime":{"gene":{"ensemblId":"ENSG00000131269","hgncId":"HGNC:48","symbol":"ABCB7","name":"ATP binding cassette subfamily B member 7"},"transcriptId":"78736fa2-71a0-4dc3-9675-e497da53a019","exon":"6cd359fc-87e1-41b8-90be-9ca397aff1af","position":7631148909251407357,"strand":"+"},"fusionPartner3prime":{"gene":{"ensemblId":"ENSG00000109576","hgncId":"HGNC:17929","symbol":"AADAT","name":"aminoadipate aminotransferase"},"transcriptId":"f79fa95a-c199-4568-959f-14f3baaea274","exon":"98a11577-0325-4199-8b6f-1c8207b4d3d4","position":5619672559603971,"strand":"-"},"effect":"RNA Fusion effect...","cosmicId":"8a43fd3b-3df4-414d-8520-571c3ad2cf77","reportedNumReads":49}],"rnaSeqs":[{"id":"RNASeq_8a6e6d50-bfd8-4c29-9003-1937ba3cc9b3","entrezId":"8a6e6d50-bfd8-4c29-9003-1937ba3cc9b3","ensemblId":"0fcf6c3b-6389-42a8-a8d3-3e724feb302c","gene":{"ensemblId":"ENSG00000129673","hgncId":"HGNC:19","symbol":"AANAT","name":"aralkylamine N-acetyltransferase"},"transcriptId":"16c9f024-d10b-48fc-b3eb-fe21455f2016","fragmentsPerKilobaseMillion":0.52,"fromNGS":false,"tissueCorrectedExpression":true,"rawCounts":393,"librarySize":97,"cohortRanking":2},{"id":"RNASeq_0ae924be-d9c2-42e2-b9eb-c946bf768da4","entrezId":"0ae924be-d9c2-42e2-b9eb-c946bf768da4","ensemblId":"347f84b9-6147-4336-bba8-bb5e8f32091d","gene":{"ensemblId":"ENSG00000260053","hgncId":"HGNC:31130","symbol":"ABCB10P4","name":"ABCB10 pseudogene 4"},"transcriptId":"68d3f08f-68c5-4c4e-a868-2a91bf6a74ef","fragmentsPerKilobaseMillion":0.5,"fromNGS":true,"tissueCorrectedExpression":false,"rawCounts":410,"librarySize":82,"cohortRanking":5},{"id":"RNASeq_4d00e0d0-76be-4071-ab10-2d1b6fd2bf32","entrezId":"4d00e0d0-76be-4071-ab10-2d1b6fd2bf32","ensemblId":"7b768481-e129-4f87-8bff-815dc5449f58","gene":{"ensemblId":"ENSG00000256661","hgncId":"HGNC:41022","symbol":"A2ML1-AS1","name":"A2ML1 antisense RNA 1"},"transcriptId":"488b86f2-668b-4d75-a784-8267757b5cdd","fragmentsPerKilobaseMillion":0.55,"fromNGS":true,"tissueCorrectedExpression":false,"rawCounts":968,"librarySize":47,"cohortRanking":2},{"id":"RNASeq_ceeb241f-6dbd-4e55-9c34-666c44e46405","entrezId":"ceeb241f-6dbd-4e55-9c34-666c44e46405","ensemblId":"5a0783cb-48ff-4cde-98b1-e2b8ea31a9f4","gene":{"ensemblId":"ENSG00000141338","hgncId":"HGNC:38","symbol":"ABCA8","name":"ATP binding cassette subfamily A member 8"},"transcriptId":"972fda4e-a47b-43b0-b574-9dc688d668f5","fragmentsPerKilobaseMillion":0.71,"fromNGS":true,"tissueCorrectedExpression":true,"rawCounts":294,"librarySize":35,"cohortRanking":3},{"id":"RNASeq_475d891e-030f-490e-b741-030b965877c0","entrezId":"475d891e-030f-490e-b741-030b965877c0","ensemblId":"66d9d63f-8b6e-4de7-baa3-e6be55497c77","gene":{"ensemblId":"ENSG00000197150","hgncId":"HGNC:49","symbol":"ABCB8","name":"ATP binding cassette subfamily B member 8"},"transcriptId":"7af2745c-811f-481a-a288-81456117a9fa","fragmentsPerKilobaseMillion":0.04,"fromNGS":true,"tissueCorrectedExpression":false,"rawCounts":371,"librarySize":68,"cohortRanking":8}]}],"carePlans":[{"id":"6a3601ea-8fba-437d-8add-bf4f4cce469e","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","diagnosis":"ed1f151c-0707-4bbf-bb02-9654310ac1f8","issuedOn":"2023-12-14","description":"MTB conference protocol...","recommendations":["df376556-df45-41c3-8bae-af1fe3fb7418","08234e1e-105c-4362-87e8-4f20bf87ed0b"],"geneticCounsellingRequest":"65344fca-0028-4129-a530-dd36fd984bd3","rebiopsyRequests":["5f54fb43-92a5-4f62-ae48-081d428ff2e8"],"studyInclusionRequests":["d49b41ff-e2df-499f-938f-8fb7136366b2"]}],"recommendations":[{"id":"df376556-df45-41c3-8bae-af1fe3fb7418","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","diagnosis":"ed1f151c-0707-4bbf-bb02-9654310ac1f8","issuedOn":"2023-12-14","medication":[{"code":"L01XE39","system":"ATC","display":"Midostaurin","version":"2020"},{"code":"L01XX42","system":"ATC","display":"Panobinostat","version":"2020"}],"priority":"4","levelOfEvidence":{"grading":{"code":"m1B","system":"MTB-CDS:Level-of-Evidence:Grading"},"addendums":[{"code":"R","system":"MTB-CDS:Level-of-Evidence:Addendum"},{"code":"is","system":"MTB-CDS:Level-of-Evidence:Addendum"}]},"ngsReport":"223e3e6e-d99b-415e-83c0-18bcfc5729ca","supportingVariants":["CNV_AAGAB_ABCA6_high-level-gain","CNV_AAMP_AADACL3_low-level-gain","SNV_7f35df9d-d8b1-4421-9ec7-35cf8d3c4546"]},{"id":"08234e1e-105c-4362-87e8-4f20bf87ed0b","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","diagnosis":"ed1f151c-0707-4bbf-bb02-9654310ac1f8","issuedOn":"2023-12-14","medication":[{"code":"L01XX42","system":"ATC","display":"Panobinostat","version":"2020"},{"code":"L01XE12","system":"ATC","display":"Vandetanib","version":"2020"}],"priority":"4","levelOfEvidence":{"grading":{"code":"m1A","system":"MTB-CDS:Level-of-Evidence:Grading"},"addendums":[{"code":"R","system":"MTB-CDS:Level-of-Evidence:Addendum"},{"code":"is","system":"MTB-CDS:Level-of-Evidence:Addendum"},{"code":"iv","system":"MTB-CDS:Level-of-Evidence:Addendum"}]},"ngsReport":"223e3e6e-d99b-415e-83c0-18bcfc5729ca","supportingVariants":["CNV_AAGAB_ABCA6_high-level-gain","CNV_ABCA12_AASDHPPT_ABCC2_AARS1P1_high-level-gain","SNV_963a3ea1-a1d5-4a52-b8d4-2e969be74b7b","SNV_7f35df9d-d8b1-4421-9ec7-35cf8d3c4546","CNV_AAAS_AADAT_high-level-gain","CNV_ABALON_ABCA17P_high-level-gain","CNV_AAMP_AADACL3_low-level-gain","SNV_22f943fd-ad99-48af-a61e-42679e851b71","SNV_599c38d4-af9f-416c-ad38-eb2fee8159e1"]}],"geneticCounsellingRequests":[{"id":"65344fca-0028-4129-a530-dd36fd984bd3","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","issuedOn":"2023-12-14","reason":"Some reason for genetic counselling..."}],"rebiopsyRequests":[{"id":"5f54fb43-92a5-4f62-ae48-081d428ff2e8","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","specimen":"40043ae5-d4cb-48e4-85c6-b34266b7693f","issuedOn":"2023-12-14"}],"histologyReevaluationRequests":[{"id":"b76dfb95-13e8-4acb-9ab8-364bc5215d63","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","specimen":"40043ae5-d4cb-48e4-85c6-b34266b7693f","issuedOn":"2023-12-14"}],"studyInclusionRequests":[{"id":"d49b41ff-e2df-499f-938f-8fb7136366b2","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","reason":"ed1f151c-0707-4bbf-bb02-9654310ac1f8","nctNumber":"NCT84044685","issuedOn":"2023-12-14"}],"claims":[{"id":"2280a457-c5b8-4541-b6ca-86de385d789f","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","issuedOn":"2023-12-14","therapy":"df376556-df45-41c3-8bae-af1fe3fb7418"},{"id":"061fde0a-935c-4e2f-a54a-531679b2f8d5","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","issuedOn":"2023-12-14","therapy":"08234e1e-105c-4362-87e8-4f20bf87ed0b"}],"claimResponses":[{"id":"1177f670-cf44-4886-b9b3-a4dd25271dcb","claim":"2280a457-c5b8-4541-b6ca-86de385d789f","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","issuedOn":"2023-12-14","status":"accepted","reason":"standard-therapy-not-exhausted"},{"id":"c85d365d-e3c1-474b-aaa3-0e3e051d4223","claim":"061fde0a-935c-4e2f-a54a-531679b2f8d5","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","issuedOn":"2023-12-14","status":"rejected","reason":"other"}],"molecularTherapies":[{"history":[{"id":"88801f10-9f77-4a5d-adc1-47dd97b7e9ea","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","recordedOn":"2023-12-14","basedOn":"df376556-df45-41c3-8bae-af1fe3fb7418","period":{"start":"2023-12-14","end":"2023-12-14"},"medication":[{"code":"L01XE39","system":"ATC","display":"Midostaurin","version":"2020"},{"code":"L01XX42","system":"ATC","display":"Panobinostat","version":"2020"}],"dosage":">=50%","reasonStopped":{"code":"medical-reason","system":"MTB-CDS:MolecularTherapy:StopReason"},"note":"Notes on the Therapy...","status":"stopped"}]},{"history":[{"id":"660813fd-a42d-492a-8522-9c4aa3b3e162","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","recordedOn":"2023-12-14","basedOn":"08234e1e-105c-4362-87e8-4f20bf87ed0b","period":{"start":"2023-12-14","end":"2023-12-14"},"medication":[{"code":"L01XX42","system":"ATC","display":"Panobinostat","version":"2020"},{"code":"L01XE12","system":"ATC","display":"Vandetanib","version":"2020"}],"dosage":"<50%","note":"Notes on the Therapy...","status":"completed"}]}],"responses":[{"id":"267cddc7-50fd-43e6-90e6-a7f2806c7da2","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","therapy":"88801f10-9f77-4a5d-adc1-47dd97b7e9ea","effectiveDate":"2023-12-14","value":{"code":"SD","system":"RECIST"}},{"id":"8b2af33e-afee-450b-b947-3370d89603f8","patient":"5dad2f0b-49c6-47d8-a952-7b9e9e0f7549","therapy":"660813fd-a42d-492a-8522-9c4aa3b3e162","effectiveDate":"2023-12-14","value":{"code":"CR","system":"RECIST"}}]}